Clinical Trial Update: Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children [Phase 4]

View source ↗

Summary

A Phase 4 trial update on atomoxetine for treating attention deficit hyperactivity disorder in young children has been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Disorder with Hyperactivity

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: University of Nebraska | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 4 | Status: COMPLETED | Results posted: 2013-07-17